Evidence map›Paper›PMID 40155188›Full record

ArticleJACC. Advances2025

Physicians' Perspectives on a Best Practice Alert to Improve Guideline-Directed Medical Therapy in Heart Failure.

David T Zhang, Ramsey K Kalil, Ozan Unlu, Michael T Kim, Sabrina Mangal, Jonathan Elias, Parag Goyal

Abstract read
In one paragraph

Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David T ZhangDivision of Cardiology, Department of Medicine, Stony Brook Medicine, Stony Brook, New York, USA.
Ramsey K KalilDivision of Cardiology, Texas Heart Institute, Houston, Texas, USA.
Ozan UnluDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Michael T KimDepartment of Medicine, Weill Cornell Medicine, New York, New York, USA.
Sabrina MangalDepartment of Biobehavioral Nursing and Health Informatics, University of Washington School of Nursing, Seattle, Washington, USA.
Jonathan EliasDepartment of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
Parag GoyalProgram for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Electronic address: pag9051@med.cornell.edu.

Funding

A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and PolypharmacyK76AG064428 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI GOYAL, PARAG · 2020 to 2024
$1.1M
NIA NIH HHS K76 AG064428
6 · The paper itself

Abstract

backgroundMineralocorticoid receptor antagonists (MRAs) are disease-modifying agents indicated for heart failure (HF) that can augment diuresis and treat hypokalemia but are underutilized. Prescribing MRAs instead of potassium supplements to treat hypokalemia in the setting of HF could increase the use of MRAs. A best practice alert (BPA) in the electronic medical record that suggests ordering an MRA instead of potassium supplementation for a HF patient with hypokalemia could facilitate this.

objectivesThis study sought to examine perspectives of primary care physicians on MRA utilization and BPA usefulness and to develop a novel conceptual model for guiding future BPA development.

methodsWe conducted one-on-one semistructured interviews with primary care physicians until we reached thematic saturation to understand facilitators and barriers of MRA prescription, BPA usage, and our specific BPA. Two coders independently reviewed each interview transcript using directed content analysis. Codes were collated into subthemes and themes.

resultsWe interviewed 10 participants. We mapped our themes onto the Capability, Opportunity, Motivation, Behavior (COM-B) model, a well-established model that focuses on influential factors of behavior change. Based on these findings, we created a BPA-specific framework that reflects the necessary components for changing medication-prescribing behavior.

conclusionsWe generated a conceptual model to guide development of future BPAs focused on changing medication-prescribing practice based on the COM-B model, using MRAs as a prototype for development.

Indexed as

best practice alertguideline-directed medical therapymineralocorticoid receptor antagonist

Identifiers

PMID40155188
PMCPMC11994041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.